FULGENT GENETICS, INC. Deferred Income Tax Liabilities, Net
FULGENT GENETICS, INC. (FLGT) had Deferred Income Tax Liabilities, Net of $6.89 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-07-30
- 2026-06-30: Deferred Income Tax Liabilities, Net $6.89M.
- 2026-03-31: Deferred Income Tax Liabilities, Net $6.98M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $6.94M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $7.04M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $6.89M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $6.98M 10-Q · filed 2026-05-01 |
| 2025-12-31 | $6.94M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $7.04M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $6.12M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $6.24M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $6.37M 10-K · filed 2026-02-27 |
| 2024-09-30 | $6.73M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $6.95M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $7.41M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $7.96M 10-K · filed 2025-02-28 |
| 2023-09-30 | $9.83M 10-Q · filed 2023-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |